Codex DNA (NASDAQ:DNAY) CEO Todd Nelson Details the Investment Opportunity for mRNA and DNA Replication
Todd Nelson, CEO, describes Codex DNA (NASDAQ:DNAY) in this 1,921 word interview, exclusively in the Wall Street Transcript.
Source: twst.com
Page 7 - Wall Street Transcript News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Wall Street Transcript. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Wall Street Transcript Today - Breaking & Trending Today
Psilocybin Magic Mushrooms are Now a Publicly Traded Investment Vehicle: COMPASS Pathways (NASDAQ:CMPS)
A 3,683 word interview with George Goldsmith the CEO of COMPASS Pathways (NASDAQ:CMPS) on investing in psilocybin magic mushrooms.
Source: twst.com
Angion Biomedica (NASD: ANGN) CEO Focus on Primary Proteinuric Kidney Diseases
Interview with Jay Venkatesan, M.D., the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. (ANGN).
Source: twst.com
Vyant Bio (NASD: VYNT) is on the Cutting Edge of Biotech Drug Development
Interview with Jay Roberts has been the President and Chief Executive Officer of Vyant Bio (NASD: VYNT) a leader in biotech drug development.
Source: twst.com
GenSight Biologics SA (GSGTF) is Developing the Leber Hereditary Optic Neuropathy Cure
Interview with Bernard Gilly the Co-Founder and CEO: GenSight Biologics SA (OTCMKTS:GSGTF) describes the status of their mitochondrial drug treatments.
Source: twst.com